Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

DegludecPlus effective in type 2 diabetes in proof-of-concept trial

July 14, 2010

Phase III data reveal effects of add-on dapagliflozin in poorly controlled diabetes

July 14, 2010

Ostarine increases lean body mass and leg strength in postmenopausal women

July 14, 2010

Viamet describes new cytochrome P450-C17 inhibitors

July 13, 2010

Exelixis presents preclinical data on agents investigated for diabetes

July 13, 2010

Weekly rituximab reduces proteinuria in idiopathic membranous nephropathy

July 13, 2010

BHT-3021 shows promise in phase I/II trial in type 1 diabetes

July 13, 2010

Effect of citalopram on drinking depends on goals of alcohol-dependent subjects

July 13, 2010

Phase I data presented on SBI-087 in RA and SLE

July 12, 2010

Ardea describes next-generation URAT-1 inhibitor RDEA-684

July 12, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...